LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics

...

GRAIL Details Plans for Early Cancer Detection Trials, Products

VC-backed GRAIL Appoints Cook as CEO

Early Cancer Detection Startup GRAIL Closes on $900 Million in Series B Funding

LinkedIn Top Companies: The 50 Most Sought-after Startups

Early Cancer-Detection Startup GRAIL is Reportedly Trying to Raise More Money

PARP Inhibitor May Be Effective Against Some TNBC-Lacking BRCA Mutations

How Science is Unlocking the Cancer Medicines of the Future

Genomic Medicine Has Entered the Building

Healthcare is Looking to the Tech World for Recruitment

  • 1
  • 2
  • 3
  • 4
  • 5
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • Through reverse auctions, Minnesota pushes for PBM savings and price transparency

  • Matternet Tests Longest Drone Delivery Route Between Hospitals and Labs in Switzerland

  • Matternet Set to Produce M2 Delivery Drones in the US After Receiving FAA Greenlight

  • Running Through Walls: Thinking Long Term is the Greatest Gift

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn